SAW
BMY icon

Signal Advisors Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Signal Advisors Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Sell
7,813
-39
-0.5% -$2.24K 0.02% 439
2026
Q1 		$476K Buy
7,852
+539
+7% +$31.4K 0.03% 373
2025
Q4 		$394K Sell
7,313
-4,668
-39% -$225K 0.03% 353
2025
Q3 		$540K Sell
11,981
-17,177
-59% -$802K 0.05% 258
2025
Q2 		$1.35M Buy
+29,158
New +$1.43M 0.11% 179

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Signal Advisors Wealth's BMY Position: Q2 2026 in Review

Signal Advisors Wealth reduced its Bristol-Myers Squibb (BMY) stake by 0.5% in Q2 2026, selling an estimated $2.24K and leaving 7,813 shares worth $450K. The position accounts for 0.02% of the portfolio, ranked #439.

Signal Advisors Wealth first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.35M in Q2 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Signal Advisors Wealth held 7,813 shares of Bristol-Myers Squibb worth $450K as of Q2 2026.
  • Signal Advisors Wealth sold 39 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.24K.
  • Bristol-Myers Squibb made up 0.02% of Signal Advisors Wealth's portfolio in Q2 2026, its #439 holding.
  • Signal Advisors Wealth first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
  • Signal Advisors Wealth's Bristol-Myers Squibb position peaked at $1.35M in Q2 2025.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.